Evidence map›Paper›PMID 41327442›Full record

ArticleParasites & vectors2025

Measuring elimination of gambiense human African trypanosomiasis: a comparison of deceptively different metrics.

Samuel A Sutherland, Jason J Madan, Kat S Rock

Abstract readComparative Study
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samuel A SutherlandThe Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, University of Warwick, University Road, Coventry, CV4 7AL, United Kingdom. Samuel.A.Sutherland@warwick.ac.uk.
Jason J MadanCentre for Health Economics at Warwick, Warwick Medical School, University of Warwick, University Road, Coventry, CV4 7AL, United Kingdom.
Kat S RockThe Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, University of Warwick, University Road, Coventry, CV4 7AL, United Kingdom.

Funding

Gates Foundation INV-005121
6 · The paper itself

Abstract

Modelling is an effective and widely used tool for predicting the future trajectory of infectious diseases. One of its strengths is its ability to measure and predict metrics that are unobservable in real life, such as the true prevalence, or when infection events occur. Policy goals, on the other hand, must necessarily be based on observable metrics in order to be verifiable. The WHO has targeted gambiense human African trypanosomiasis (gHAT) for elimination of transmission (EoT) by 2030. In order to verify this, the WHO HAT Elimination Technical Advisory Group (HAT-e-TAG) has recently defined the country-level indicator for EoT as 5 years of no new locally-infected reported cases, along with a sufficient level of surveillance. While this indicator is a useful and concrete metric that can be clearly measured, it does not directly measure the actual transmission or prevalence of the disease. In some cases, the timing of the last transmission event or the point when infection is no longer present in a country may differ quite substantially from when the country reaches the WHO indicator for EoT. In this article, we discuss the difference between these different metrics and show with some examples how much they can disagree. Furthermore, modelling papers have previously been published using various approximations of EoT, which has the potential to cause confusion. In this paper, we highlight the potential misunderstandings which could occur due to seemingly trivial differences in the definition of elimination and its indicators, especially in the context of such a slow-progressing disease as gHAT. We conclude that while there is value in models predicting both observable and unobservable metrics, modellers need to ensure that they are clear about definitions when communicating results, and policymakers need to be sure that they know what definitions are being used when drawing conclusions from model results. While this paper focuses specifically on three indicators of EoT for gHAT, the general points made here could have applications in other infections approaching the endgame, such as onchocerciasis, or even beyond public health.

Indexed as

Disease EradicationTrypanosoma brucei gambienseTrypanosomiasis, AfricanHumansPrevalenceWorld Health OrganizationDisease monitoringDisease surveillanceEliminationHuman African trypanosomiasisModellingNeglected tropical diseasesSleeping sicknessTerminologyWorld Health Organisation

Identifiers

PMID41327442
PMCPMC12771873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.